Abstract
Bioethical debates on stem cell research have focused primarily on the moral status of human embryos. This article highlights seven distinct policy and ethical issues associated with the commercialisation of stem cell therapies, describes some of the underlying moral questions on which they turn, and argues that there is an urgent need to refocus the debate on stem cell research beyond the controversy over embryo destruction.
| Original language | English |
|---|---|
| Pages (from-to) | 23-36 |
| Number of pages | 14 |
| Journal | Journal of Law and Medicine |
| Volume | 29 |
| Issue number | 1 |
| Publication status | Published - 1 Mar 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- commercialisation of therapies
- destruction
- human embryos
- stem cell research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver